Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860)
Potential amendments to the SNAP program in the farm bill
Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products (no bill numbers yet)
Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)
Duration: July 15, 2009
to
present
General Issues: Budget/Appropriations , Agriculture , Food Industry (Safety, Labeling, etc.) , Taxation/Internal Revenue Code , Trade (Domestic & Foreign) , Health Issues , Law Enforcement/Crime/Criminal Justice , Consumer Issues/Safety/Protection
Spending: about $1,120,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2009: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), U.S. Senate,, Federal Trade Commission (FTC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Patricia Knight
Chief of Staff/Health Policy Director, Sen. Orrin G. Hatch
DAsst Sec for Legis/Acting DAS for Legis/DHHS
Princpl DAS for Legis & Intergvtl, Dept of Commerce
Minority Clerk, House Appropriations Cmte
Chief of Staff, Sen. Orrin G. Hatch
Chief of Staff, Senator Orrin G. Hatch
Chief of Staff, Hlth Polcy Dir, Sen. Orrin Hatch
previously listed
Previously listed
Health Policy Dir, Sen. Orrin G. Hatch
Acting DAS/DAS for Legis, DHHS
Prncpl DAS for Legis/Intrgvtl Affairs, DofCmmrce
Prof Staff Member, House Approps Cmte
Previously Listed
Health Policy Dir, Sen. Orrin Hatch
Prin DAS for Legis/Intgvtl Affrs, Dept of Cmmrce
Professional Staff, House Approps Cmte
Chief of Staff, Senator Orrin Hatch
Patricia Knight cont'd
Actg DAS/DAS for Legis, DHHS
Prin DAS for Leg/Intergvtl Affrs, Dept of Cmrce
Prof Staff, Hse Apprps Cmte
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 23.
Original Filing: 301577028.xml
Lobbying Issues
Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Potential amendments to the SNAP program in the farm bill
Lobbying Issues
Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products (no bill numbers yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2023
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 22.
Original Filing: 301541080.xml
Lobbying Issues
Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Potential amendments to the SNAP program in the farm bill
Lobbying Issues
Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products (no bill numbers yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2023
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 14, 2023.
Original Filing: 301500741.xml
Lobbying Issues
Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriation; the Continuing Appropriations Act, 2024 (HR 5860)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Potential amendments to the SNAP program in the farm bill (no bill number yet)
Lobbying Issues
Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products (no bill numbers yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
Legislation to allow HSA/FSA coverage of dietary supplements (HR 5967, HSA Modernization Act)
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2023
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 16, 2023.
Original Filing: 301477018.xml
Lobbying Issues
Funding for the Food and Drug Administration regulation of dietary supplement products, HR 4368/ S 2131 Fy 2024 Agriculture Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Potential amendments to the SNAP program in the farm bill (no bill number yet)
Lobbying Issues
Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (S 1339, pharmacy Benefit Manger Reform Act) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products (no bill numbers yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
Legislation to allow HSA/FSA coverage of dietary supplements (no bill number yet)
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2023
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 20, 2023.
Original Filing: 301465229.xml
Lobbying Issues
Funding for the Food and Drug Administration regulation of dietary supplement products, no specific legislation
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Potential amendments to the SNAP program in the farm bill (no bill number yet)
Lobbying Issues
Potential amendments related to dietary supplements in HELP Committee legislation being developed with respect to pharmaceutical pricing and consumer access (no bill yet) Legislation being developed to clarify Food and Drug Administration regulation of hemp-derived/CBD products.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2022
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435502.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement for FY 2023 - (HR 2617- Consolidated Appropriations Act of 2023 (PL 117-327).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Potential dietary supplement mandatory product listing program (S. 4090), Dietary Supplement Listing Act, (S. 4348, Food and Drug Administration Safety and Landmark Advancement Act FDASLA, no House companion measure (PL 117-328, Consolidated Appropriations Act, 2023).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2022
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 17, 2022.
Original Filing: 301406271.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2023 Agriculture Appropriations or the FY 2023 continuing resolution (PL 117-103).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Potential dietary supplement mandatory product listing program (S. 4090), Dietary Supplement ListingAct, (S. 4348, Food and Drug Administration Safety and Landmark Advancement Act FDASLA, no House companion measure, FZy 2023 continuing resolution (PL 117-103).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2022
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 20, 2022.
Original Filing: 301394822.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2023 Agriculture Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Potential dietary supplement mandatory product listing program (S. 4090), Dietary Supplement ListingAct, (S. 4348, Food and Drug Administration Safety and Landmark Advancement Act FDASLA, no House companion measure.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2022
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 22, 2022.
Original Filing: 301373106.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2023 Agriculture Appropriations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Need for FDA action to clarify regulation of dietary supplement products containing hemp/CBD, including H.R. 841, Hemp and Hemp-Derived Consumer Protection and Market Stabilization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2021
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 18, 2022.
Original Filing: 301326384.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2022 Agriculture Appropriations (HR 4356)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Need for FDA action to clarify regulation of dietary supplement products containing hemp/CBD, including H.R. 841, Hemp and Hemp-Derived Consumer Protection and Market Stabilization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2021
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 18, 2021.
Original Filing: 301302667.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2022 Agriculture Appropriations (HR 4356)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Need for FDA action to clarify regulation of dietary supplement products containing hemp/CBD, including H.R. 841, Hemp and Hemp-Derived Consumer Protection and Market Stabilization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2021
Knight Capitol Consultants amended a lobbying report for representation of United Natural Products Alliance in Q32021 on Oct. 18, 2021.
Original Filing: 301302690.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2022 Agriculture Appropriations (HR 4356)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Need for FDA action to clarify regulation of dietary supplement products containing hemp/CBD, including H.R. 841, Hemp and Hemp-Derived Consumer Protection and Market Stabilization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2021
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 15, 2021.
Original Filing: 301276621.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement. FY 2022 Agriculture Appropriations (HR 4356)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Need for FDA action to clarify regulation of dietary supplement products containing hemp/CBD, including H.R. 841, Hemp and Hemp-Derived Consumer Protection and Market Stabilization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2021
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 20, 2021.
Original Filing: 301268076.xml
Lobbying Issues
Adequacy of Food and Drug Administration budget for dietary supplement policy making and enforcement.
Lobbying Issues
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Need for FDA action to clarify regulation of dietary supplement products containing hemp/CBD, including H.R. 841, Hemp and Hemp-Derived Consumer Protection and Market Stabilization Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2020
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 25, 2021.
Original Filing: 301246710.xml
Lobbying Issues
Potential language affecting: adequacy of appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in the Consolidated Appropriations Act 2021 (PL 116-260)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334), including H.R. 5587, regarding regulation of hemp-derived cannabidiol.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Regulation of CBD as a dietary supplement.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2020
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 20, 2020.
Original Filing: 301224011.xml
Lobbying Issues
Potential language affecting: adequacy of appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in any appropriations bills for FY 2021 (or successor bills to: PL 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act; PL 116-127,Families First Coronavirus Response Act; and PL 116-136, CARES Act.)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334), including H.R. 5587, regarding regulation of hemp-derived cannabidiol.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Regulation of CBD as a dietary supplement.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2020
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 18, 2020.
Original Filing: 301193351.xml
Lobbying Issues
Potential language affecting: appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in any appropriations bills for FY 2021 (or successor bills to: PL 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act; PL 116-127,Families First Coronavirus Response Act; and PL 116-136, CARES Act.)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334), including H.R. 5587, regarding regulation of hemp-derived cannabidiol.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Potential tariffs for essential oils imported from Europe
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Regulation of CBD as a dietary supplement.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2020
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 18, 2020.
Original Filing: 301172032.xml
Lobbying Issues
Potential language affecting: appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in any further appropriations bills for FY 2020 (including PL 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act; PL 116-127,Families First Coronavirus Response Act; and PL 116-136, CARES Act.)
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334).
Lobbying Issues
Potential tariffs for essential oils imported from Europe
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Regulation of CBD as a dietary supplement.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2019
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 23, 2020.
Original Filing: 301130230.xml
Lobbying Issues
Potential language affecting: appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in the Agriculture Appropriations Bill (H.R. 3164) and then the Further Consolidated Appropriations Act (PL 116-94).
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Potential tariffs for essential oils imported from Europe
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2019
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 21, 2019.
Original Filing: 301077564.xml
Lobbying Issues
Potential language affecting: appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in the Agriculture Appropriations bill (S. 2522)
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Potential tariffs for essential oils imported from Europe
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2019
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 27, 2019.
Original Filing: 301060140.xml
Lobbying Issues
Potential language affecting: appropriations for FDA regulation of dietary supplements; regulation of CBD as a dietary supplement in the Agriculture Appropriations bill (HR 3055/no Senate number yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2019
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 17, 2019.
Original Filing: 301027605.xml
Lobbying Issues
Potential language affecting regulation of CBD as a dietary supplement in the Agriculture Appropriations bill (no bill yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of the hemp farming provisions of the Agriculture Improvement Act of 2018 (P.L. 115-334).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2018
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance . The report was filed on Jan. 17, 2019.
Original Filing: 301007459.xml
Lobbying Issues
Funding for the Food and Drug Administration and the Office of Dietary Supplements (H.R. 5961, S. 2976)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Inclusion of SNAP provision covering multivitamin supplements in 2018 Farm Bill; McConnell amendment legalizing industrial hemp to Agriculture Improvement Act of 2018 (P.L. 115-334)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2018
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 22, 2018.
Original Filing: 300994254.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (Agriculture appropriations bill, H.R. 5961)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coverage of multivitamins in Health Savings Act of 2017 (HR 1175/S 403)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Inclusion of SNAP provision covering multivitamin supplements in 2018 Farm Bill (H.R. 2); McConnell amendment legalizing industrial hemp to Agriculture Improvement Act of 2018 (S. 3042)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2018
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 19, 2018.
Original Filing: 300971812.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (Agriculture appropriations bill)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coverage of multivitamins in Health Savings Act of 2017 (HR 1175/S 403)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Inclusion of SNAP provision covering multivitamin supplements in 2018 Farm Bill (H.R. 2); McConnell amendment legalizing industrial hemp to Agriculture Improvement Act of 2018 (S. 3042)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2018
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 19, 2018.
Original Filing: 300949488.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (FY 2018 Consolidated Appropriations Act (HR 1605/P.L. 115-141))
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coverage of multivitamins in Health Savings Act of 2017 (HR 1175/S 403); possible inclusion in PL 115-141, Consolidated Appropriations Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Possible inclusion of SNAP provision covering multivitamin supplements in 2018 Farm Bill (H.R. 3841)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2017
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance . The report was filed on Jan. 22, 2018.
Original Filing: 300934009.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (FY 2018 Agriculture, Rural Development and Related Agencies Appropriations H.R. 3268; and continuing resolutions HR 601; HJRes. 123; HR 1370.)
Lobbying Issues
Possible dietary supplement-related amendments to the Food and Drug Administration Reauthorization Act (P.L. 115-52)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coverage of multivitamins in Health Savings Act of 2017 (HR 1175/S 403)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2017
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910165.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (FY 2018 Agriculture, Rural Development and Related Agencies Appropriations H.R. 3268)
Lobbying Issues
Possible dietary supplement-related amendments to the Food and Drug Administration Reauthorization Act (P.L. 115-52)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Coverage of multivitamins in Health Savings Act of 2017 (HR 1175/S 403)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2017
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 19, 2017.
Original Filing: 300890898.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (FY 2018 Agriculture, Rural Development and Related Agencies Appropriations H.R. 3268)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Possible dietary supplement-related amendments to the Food and Drug Administration Reauthorization Act (H.R.2430; S.934)
Lobbying Issues
Coverage of multivitamins in Health Savings Act of 2017 (HR 1175/S 403)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2017
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 12, 2017.
Original Filing: 300864385.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration (further appropriations for FY 2017, no bill number yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Possible dietary supplement-related amendments to the Prescription Drug User Fee Amendments Act for 2017 (no bill number yet)
Lobbying Issues
Free Speech About Science Act (no bill number)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
Lobbying Issues
Health Savings Act of 2017 (HR 1175/S 403)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2016
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855973.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration with respect to dietary supplements- Agriculture Appropriations for FY 2017 (Further Continuing and Security Assistance Appropriations Act, PL 114-254)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills. Possible dietary supplement-related amendments to the Further Continuing and Security Assistance Appropriations Act (PL 114-254) and the National Defense Authorization Act (PL 114-328).
Lobbying Issues
Free Speech About Science Act (no legislation introduced yet).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2016
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 20, 2016.
Original Filing: 300839101.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration with respect to dietary supplements- Agriculture Appropriations for FY 2017 (HR 3049/S1800)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills. Possible dietary supplement-related amendments the National Defense Authorization Act (S. 2943).
Lobbying Issues
Free Speech About Science Act (no legislation introduced yet).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2016
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 18, 2016.
Original Filing: 300811806.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration with respect to dietary supplements- Agriculture Appropriations for FY 2017 (HR 3049/S1800)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills. Possible dietary supplement-related amendments the National Defense Authorization Act (S. 2943).
Lobbying Issues
Free Speech About Science Act (no legislation introduced yet).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2016
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 19, 2016.
Original Filing: 300796489.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration with respect to dietary supplements (bill not introduced yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills. Possible dietary supplement-related amendments to pending legislation.)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Free Speech About Science Act (no legislation introduced yet).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2015
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 20, 2016.
Original Filing: 300781620.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration with respect to dietary supplements (HR 3049, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Programs for FY 2016/H.R. 2090 Consolidated Appropriations Act (PL 114-113).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills. Possible dietary supplement-related amendments to pending legislation.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Free Speech About Science Act (no legislation introduced yet).
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2015
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 22, 2015.
Original Filing: 300766369.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration in the President's budget, the congressional budget resolution and appropriations bills (HR 3049, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Programs for FY 2016).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills); Possible dietary supplement-related amendments to Defense Authorization Act (HR 1735).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of the Food Safety and Modernization Act with respect to the dietary supplement industry (no specific bills). Free Speech About Science Act (no legislation introduced yet).
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2015
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 17, 2015.
Original Filing: 300738378.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration in the President's budget, the congressional budget resolution and appropriations bills (HR 3049, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Programs for FY 2016).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (No specific bills); Blumenthal/Durbin amendments (SA 1560, 1561, 1562) to Defense Authorization Act (HR 1735).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of the Food Safety and Modernization Act with respect to the dietary supplement industry (no specific bills).
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2015
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 20, 2015.
Original Filing: 300723849.xml
Lobbying Issues
Adequacy of funding for the Food and Drug Administration in the President's budget, the congressional budget resolution and appropriations bills.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food and Drug Administration regulation of dietary supplements (no specific legislation)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of the Food Safety and Modernization Act with respect to the dietary supplement industry.
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2014
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 20, 2015.
Original Filing: 300705891.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (HR 83, Consolidated and Further Continuing Appropriations Act, 2015 (PL 113-235).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", legislation pertaining to the labeling of Genetically Modified Organisms (HR 1699/S 809-Genetically Engineered Food Right to Know Act) and the Dietary Supplement Labeling Act (S 1425)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Draft legislation to modernize cosmetic regulation and its potential impact on dietary supplements (no bill number).
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2014
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 20, 2014.
Original Filing: 300688032.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (HR 4800/S. 2380, Agriculture Appropriations).
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", legislation pertaining to labeling of Genetically Modified Organisms (S. 809/H.R. 1699, Genetically Engineered Food Right to Know Act), and the Dietary Supplement Labeling Act (S. 1425).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Draft legislation to modernize cosmetic regulation and its potential impact on dietary supplements (no bill number yet).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2014
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 18, 2014.
Original Filing: 300662869.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (HR 4800/S. 2380, Agriculture Appropriations).
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", legislation pertaining to labeling of Genetically Modified Organisms (S. 809/H.R. 1699, Genetically Engineered Food Right to Know Act), and the Dietary Supplement Labeling Act (S. 1425).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Labeling of dietary supplement products, including measures such as the Free Speech About Science Act (no legislation introduced)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2014
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 23, 2014.
Original Filing: 300670407.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994. (No bill numbers yet)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", implementation of Food Safety Law (P.L. 111-353), legislation pertaining to labeling of Genetically Modified Organisms (S. 809/H.R. 1699, Genetically Engineered Food Right to Know Act), and the Dietary Supplement Labeling Act (S. 1425).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Labeling of dietary supplement products, including measures such as the Free Speech About Science Act (no legislation introduced)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2013
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 21, 2014.
Original Filing: 300624848.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; provisions in bills making appropriations for FDA (H.R. 2410/S. 1244) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", implementation of Food Safety Law (P.L. 111-353), and legislation pertaining to labeling of Genetically Modified Organisms (S. 809/H.R. 1699, Genetically Engineered Food Right to Know Act).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced yet)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Labeling of dietary supplement products, including measures such as the Free Speech About Science Act (no legislation introduced)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2013
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 16, 2013.
Original Filing: 300595300.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; provisions in bills making appropriations for FDA (H.R. 2410/S. 1244/H.J. Res. 59) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", implementation of Food Safety Law (P.L. 111-353), and legislation pertaining to labeling of Genetically Modified Organisms (S. 809/H.R. 1699, Genetically Engineered Food Right to Know Act).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Labeling of dietary supplement products, including measures such as the Free Speech About Science Act (no legislation introduced)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2013
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 18, 2013.
Original Filing: 300575546.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; provisions in bills making appropriations for FDA (H.R. 2410/S. 1244) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", implementation of Food Safety Law (P.L. 111-353), and legislation pertaining to labeling of Genetically Modified Organisms (S. 809/H.R. 1699, Genetically Engineered Food Right to Know Act).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced yet)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Labeling of dietary supplement products, including measures such as the Free Speech About Science Act (no legislation introduced)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2013
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 22, 2013.
Original Filing: 300560864.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; provisions in bills making appropriations for FDA (Departments of Defense, Military Construction, Veterans Affairs and Full Year Continuing Appropriations Act, PL 113-6) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues affecting dietary supplements, including implementation of the Dietary Supplement Health and Education Act and the definition of "new dietary ingredient", and implementation of Food Safety Law (P.L. 111-353).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced yet)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Labeling of dietary supplement products, including measures such as the Free Speech About Science Act (no legislation introduced)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2012
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 16, 2013.
Original Filing: 300530642.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; provisions in bills making appropriations for FDA (S. 2375/H.R. 5973, PL 112-175) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements. Dietary Supplement Labeling Act (S. 1310) and Dietary Supplement Protection Act (H.R. 3380). Possible amendments to Food and Drug Safety and Innovation Act (PL 112-144).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (Designer Anabolic Steroid Control Act - S. 3431)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2012
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Dec. 27, 2012.
Original Filing: 300524982.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; possible amendments to FDA appropriations (S. 2375/H.R. 5973) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements. Dietary Supplement Labeling Act (S. 1310) and Dietary Supplement Protection Act (H.R. 3380). Possible amendments to Food and Drug Safety and Innovation Act (PL 112-144).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (Designer Anabolic Steroid Control Act - S. 3431)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2012
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 18, 2012.
Original Filing: 300488796.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; possible amendments to FDA appropriations (S. 2375/H.R. 5973) relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements. Dietary Supplement Labeling Act (S. 1310) and Dietary Supplement Protection Act (H.R. 3380). Amendments to FDA user fee act legislation (H.R. 5651/S. 3187) affecting dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2012
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 22, 2012.
Original Filing: 300475860.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; possible amendments to FDA appropriations relating to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements. Dietary Supplement Labeling Act (S. 1310) and Dietary Supplement Protection Act (H.R. 3380). Possible amendments to prescription drug user fee act extension (no legislation yet) affecting dietary supplements, and specifically the Food and Drug Administration's proposed New Dietary Ingredient guideline.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2011
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 19, 2012.
Original Filing: 300445929.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994; possible amendments to FDA appropriations relating to dietary supplements (FDA appropriations
H.R. 2112).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements. Dietary Supplement Labeling Act (S. 1310) and Dietary Supplement Protection Act (H.R. 3380).
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
3rd Quarter, 2011
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 19, 2011.
Original Filing: 300421960.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994, (FDA appropriations H.R. 2112)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
2nd Quarter, 2011
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 20, 2011.
Original Filing: 300400582.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994, (FDA appropriations H.R. 2112)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Implementation of Food Safety Law (P.L. 111-353) and provisions related to dietary supplements.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Free Speech About Science Act (H.R. 1364)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Food Industry (Safety, Labeling, etc.)
1st Quarter, 2011
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 20, 2011.
Original Filing: 300377419.xml
Lobbying Issues
Funding for the Food and Drug Administration, and specifically for implementation of the food safety law (H.R. 1473, H.R. 1363, H.J. Res. 48, H.J. Res. 44) contained in the FY 2011 Continuing Appropriations Acts.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products, Designer Anabolic Steroid Act (no legislation introduced)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Possible Legislation Relating to Labeling of Dietary Supplements (no bill introduced yet)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Food Industry (Safety, Labeling, etc.)
4th Quarter, 2010
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance . The report was filed on Jan. 19, 2011.
Original Filing: 300345842.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (S. 3606)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food Safety Legislation (S. 510, H.R. 2751, P.L. 111-353) and provisions related to dietary supplements. Dietary Supplement Full Implementation and Enforcement Act (S. 3414)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Federal Trade Commission activities in general that affect dietary supplement companies, and FTC-related provisions contained in Dodd-Frank Wall Street Reform and Consumer Protection Act (P.L. 111-203)
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2010
Knight Capitol Consultants amended a lobbying report for representation of United Natural Products Alliance in Q32010 on Jan. 20, 2011.
Original Filing: 300349169.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (S. 3606)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food Safety Legislation (S. 510) and provisions related to dietary supplements. Dietary Supplement Full Implementation and Enforcement Act (S. 3414)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Federal Trade Commission activities in general that affect dietary supplement companies, and FTC-related provisions contained in Dodd-Frank Wall Street Reform and Consumer Protection Act (P.L. 111-203)
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2010
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 19, 2010.
Original Filing: 300326290.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (S. 3606)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food Safety Legislation (S. 510) and provisions related to dietary supplements. Dietary Supplement Full Implementation and Enforcement Act (S. 3414)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Federal Trade Commission activities in general that affect dietary supplement companies, and FTC-related provisions contained in Dodd-Frank Wall Street Reform and Consumer Protection Act (P.L. 111-203)
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
2nd Quarter, 2010
In Q2, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on July 20, 2010.
Original Filing: 300296950.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994 (S. 3606)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food Safety Legislation (S. 510) and provisions related to dietary supplements. Dietary Supplement Full Implementation and Enforcement Act (S. 3414)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Federal Trade Commission activities in general that affect dietary supplement companies, and FTC-related provisions contained in financial reform legislation (H.R. 4173)
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2010
In Q1, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on April 20, 2010.
Original Filing: 300274590.xml
Lobbying Issues
Adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food Safety Legislation (S. 510) and provisions related to dietary supplements
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Federal Trade Commission activities in general that affect dietary supplement companies
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
4th Quarter, 2009
In Q4, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Jan. 19, 2010.
Original Filing: 300238930.xml
Lobbying Issues
FY 2010 Appropriations for Agriculture and Related Agencies (H.R. 2997/S. 1406, P.L. 111-80) and provisions related to adequacy of Food and Drug Administration Funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Food Safety Legislation (H.R. 510, H.R. 759, S. 510) and provisions related to dietary supplements.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Disincentives to marketing of illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Food and Drug Administration and Federal Trade Commission activities in general that affect dietary supplement companies.
Agencies Lobbied
Food & Drug Administration (FDA) Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2009
In Q3, Knight Capitol Consultants lobbied for United Natural Products Alliance , earning $20,000. The report was filed on Oct. 19, 2009.
Original Filing: 300211494.xml
Lobbying Issues
FY 2010 Appropriations for Agriculture and Related Agencies (H.R. 2997/S. 1406) and provisions related to adequacy of Food and Drug Administration funding for implementation and enforcement of the Dietary Supplement Health and Education Act of 1994.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Food Safety Legislation (S. 510/H.R. 759) and provisions related to dietary supplements
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Disincentives to marketing on illegal steroid precursor products (no legislation introduced)
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Federal Trade Commission activities in general that affect dietary supplement companies
Agencies Lobbied
Federal Trade Commission (FTC)
Type of Issue
Consumer Issues/Safety/Protection
3rd Quarter, 2009
Knight Capitol Consultants filed a lobbying registration on Aug. 29, 2009 to represent United Natural Products Alliance, effective July 15, 2009.
Original Filing: 300198192.xml
Issue(s) they said they’d lobby about: Legislation pertaining to dietary supplements, including food safety (H.R. 2749, S. 510) .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate